Key result
Heterozygous ACTC1 variants involving residues Gly57 or Glu101 were associated with syndromic phenotypes including facial dysmorphism, short stature, skeletal anomalies, and cardiomyopathies.
Why the study?
Pathogenic variants in ACTC1 cause diverse cardiac phenotypes, and the study aimed to expand the clinical and genetic spectrum of associated phenotypes.
Case Report (n=2)
Heterozygous ACTC1 variants can cause a syndromic phenotype involving both cardiomyopathies and extracardiac developmental anomalies, expanding the known clinical spectrum of these mutations.
Answers are grounded in this paper and cite their sources.
ACTC1 variants may associate with extracardiac features in cardiomyopathy; leaves open broader phenotypic spectrum pending larger validation studies.
Individuals carrying pathogenic variants in ACTC1 present with several cardiac phenotypes, including hypertrophic cardiomyopathy, dilated cardiomyopathy, and left ventricular noncompaction cardiomyopathy. In the current work, we expand the clinical and genetic spectrum of phenotypes caused by ACTC1 genetic variants by describing two individuals with heterozygous variants involving residues Gly57 or Glu101. These individuals presented with facial dysmorphism, short stature, and skeletal anomalies in addition to hypertrophic and left ventricular noncompaction cardiomyopathies. Protein structure analysis showed these variants alter the ATP binding or putative protein-protein interactions, while in vivo zebrafish analysis validated the pathogenicity of these ACTC1 variants and their impact on the development of the cranial tissues. Combined with recent reports of other individuals with ACTC1 variants and extracardiac phenotypes, this study provides further evidence of the extensive molecular and clinical diversity related to ACTC1.
No takes yet. Share an insight, caveat, or question.
Zárate et al. (2025) conducted a case report in ACTC1 genetic variants (n=2). ACTC1 genetic variants (Gly57 or Glu101) was evaluated on Clinical and genetic spectrum of phenotypes. Heterozygous ACTC1 variants involving residues Gly57 or Glu101 were associated with syndromic phenotypes including facial dysmorphism, short stature, skeletal anomalies, and cardiomyopathies.
Synapse has enriched 10 related papers. Consider them for comparative context: